News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MedImmune, INSERM and Inserm Transfert Announce Strategic Collaboration to Fund and Conduct Medical Science Research



4/4/2011 10:23:49 AM

GAITHERSBURG, Md. & PARIS--(BUSINESS WIRE)--MedImmune, the global biologics business of AstraZeneca, and Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm), today announced a three-year strategic collaboration to advance research across a range of therapeutic areas including oncology, respiratory, inflammation, and autoimmune diseases. Research will explore translational biology and new disease mechanisms, as well as evaluate potential drug candidates.

Read at BioSpace.com


comments powered by Disqus
INSERM
MedImmune
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES